Article
Targeted therapy in thyroid cancer: molecular alterations and clinical management.
Frontiers in endocrinology - 1 Jan 2026
Yang YiHeng, Zhang YeSheng, Xu YongCan, Gu XiaoXin, Lou Neng, Ye GuoChao
Abstract excerpt
Background: This review summarizes key actionable molecular alterations in thyroid cancer and examines how molecular profiling can be translated into practical, subtype-specific targeted treatment strategies for advanced, recurrent, or radioiodine-refractory disease. Methods: A narrative synthesis was performed using evidence from landmark clinical trials, current consensus guidelines, and representative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
